FCM
RGEN icon

Fieldview Capital Management’s Repligen RGEN Stock Holding History

Fieldview Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
1,783
+39
+2% +$4.79K 0.07% 435
2026
Q1 		$205K Buy
+1,744
New +$244K 0.06% 453

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fieldview Capital Management's RGEN Position: Q2 2026 in Review

Fieldview Capital Management increased its Repligen (RGEN) stake by 2.2% in Q2 2026, buying an estimated $4.79K and bringing the position to 1,783 shares worth $243K. The position accounts for 0.07% of the portfolio, ranked #435.

Fieldview Capital Management first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Fieldview Capital Management held 1,783 shares of Repligen worth $243K as of Q2 2026.
  • Fieldview Capital Management bought 39 Repligen shares in Q2 2026, an estimated $4.79K.
  • Repligen made up 0.07% of Fieldview Capital Management's portfolio in Q2 2026, its #435 holding.
  • Fieldview Capital Management first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.